<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20190208//EN"
       "JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.4" xml:lang="en">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">Russian Journal of Biological Physics and Chemisrty</journal-id>
   <journal-title-group>
    <journal-title xml:lang="en">Russian Journal of Biological Physics and Chemisrty</journal-title>
    <trans-title-group xml:lang="ru">
     <trans-title>АКТУАЛЬНЫЕ ВОПРОСЫ БИОЛОГИЧЕСКОЙ ФИЗИКИ И ХИМИИ</trans-title>
    </trans-title-group>
   </journal-title-group>
   <issn publication-format="print">2499-9962</issn>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="publisher-id">54052</article-id>
   <article-categories>
    <subj-group subj-group-type="toc-heading" xml:lang="ru">
     <subject>НАНОБИОФИЗИКА</subject>
    </subj-group>
    <subj-group subj-group-type="toc-heading" xml:lang="en">
     <subject>NANOBIOPHYSICS</subject>
    </subj-group>
    <subj-group>
     <subject>НАНОБИОФИЗИКА</subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title xml:lang="en">THE EFFECT OF WATER SOLUBLE F-828 [C60] FULLERENE DERIVATIVE ON PROLIFERATION AND CELL DEATH OF HUMAN EMBRYONIC LUNG FIBROBLASTS</article-title>
    <trans-title-group xml:lang="ru">
     <trans-title>ВЛИЯНИЕ ВОДОРАСТВОРИМОГО ПРОИЗВОДНОГО ФУЛЛЕРЕНА С60 F-828 НА ПРОЛИФЕРАТИВНУЮ АКТИВНОСТЬ И ГИБЕЛЬ ЭМБРИОНАЛЬНЫХ ФИБРОБЛАСТОВ ЛЕГКОГО ЧЕЛОВЕКА</trans-title>
    </trans-title-group>
   </title-group>
   <contrib-group content-type="authors">
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Сергеева</surname>
       <given-names>В. А.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Sergeeva</surname>
       <given-names>V. A.</given-names>
      </name>
     </name-alternatives>
     <email>tracytheplane@gmail.com</email>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Костюк</surname>
       <given-names>С. В.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Kostyuk</surname>
       <given-names>S. V.</given-names>
      </name>
     </name-alternatives>
     <email>svet-vk@yandex.ru</email>
     <xref ref-type="aff" rid="aff-2"/>
     <xref ref-type="aff" rid="aff-3"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Ершова</surname>
       <given-names>Е. С.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Ershova</surname>
       <given-names>E. S.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-4"/>
     <xref ref-type="aff" rid="aff-5"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Каменева</surname>
       <given-names>Л. В.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Kameneva</surname>
       <given-names>L. V.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-6"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Малиновская</surname>
       <given-names>Е. М.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Malinovskaya</surname>
       <given-names>E. M.</given-names>
      </name>
     </name-alternatives>
     <email>m.elena.0402@gmail.com</email>
     <xref ref-type="aff" rid="aff-7"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Трошин</surname>
       <given-names>П. А.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Troshin</surname>
       <given-names>P. A.</given-names>
      </name>
     </name-alternatives>
     <email>troshin2003@inbox.ru</email>
     <xref ref-type="aff" rid="aff-8"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Вейко</surname>
       <given-names>Н. Н.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Veiko</surname>
       <given-names>N. N.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-9"/>
    </contrib>
   </contrib-group>
   <aff-alternatives id="aff-1">
    <aff>
     <institution xml:lang="ru">Медико-генетический научный центр им. академика Н.П. Бочкова</institution>
     <city>Москва</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Research Centre for Medical Genetics</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-2">
    <aff>
     <institution xml:lang="ru">Медико-генетический научный центр им. академика Н.П. Бочкова</institution>
     <city>Москва</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Research Centre for Medical Genetics</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-3">
    <aff>
     <institution xml:lang="ru">Федеральный научно-клинический центр реаниматологии и реабилитологии</institution>
     <city>Москва</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Federal Scientific and Clinical Center of Medical Rehabilitation and Balneology of the Federal Medical and Biological Agency of Russia</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-4">
    <aff>
     <institution xml:lang="ru">Медико-генетический научный центр им. академика Н.П. Бочкова</institution>
     <city>Москва</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Research Centre for Medical Genetics</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-5">
    <aff>
     <institution xml:lang="ru">Федеральный научно-клинический центр реаниматологии и реабилитологии</institution>
     <city>Москва</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-6">
    <aff>
     <institution xml:lang="ru">Медико-генетический научный центр им. академика Н.П. Бочкова</institution>
     <city>Москва</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Research Centre for Medical Genetics</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-7">
    <aff>
     <institution xml:lang="ru">Медико-генетический научный центр им. академика Н.П. Бочкова</institution>
     <city>Москва</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Research Centre for Medical Genetics</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-8">
    <aff>
     <institution xml:lang="ru">ФИЦ ПХФ и МХ РАН</institution>
     <city>Черноголовка</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">FRC PCPMC RAS</institution>
     <city>Chernogolovka</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-9">
    <aff>
     <institution xml:lang="ru">Медико-генетический научный центр им. академика Н.П. Бочкова</institution>
     <city>Москва</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Research Centre for Medical Genetics</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <pub-date publication-format="print" date-type="pub" iso-8601-date="2016-12-25T20:22:29+03:00">
    <day>25</day>
    <month>12</month>
    <year>2016</year>
   </pub-date>
   <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2016-12-25T20:22:29+03:00">
    <day>25</day>
    <month>12</month>
    <year>2016</year>
   </pub-date>
   <volume>1</volume>
   <issue>2</issue>
   <fpage>13</fpage>
   <lpage>17</lpage>
   <history>
    <date date-type="received" iso-8601-date="2016-12-20T20:22:29+03:00">
     <day>20</day>
     <month>12</month>
     <year>2016</year>
    </date>
    <date date-type="accepted" iso-8601-date="2016-12-20T20:22:29+03:00">
     <day>20</day>
     <month>12</month>
     <year>2016</year>
    </date>
   </history>
   <self-uri xlink:href="https://rusjbpc.ru/en/nauka/article/54052/view">https://rusjbpc.ru/en/nauka/article/54052/view</self-uri>
   <abstract xml:lang="ru">
    <p>В последнее время все больше внимания в мире уделяется нанотехнологиям. Применение наноматериалов в медицине сопряжено с определенными рисками, связанными с воздействием этих материалов на клетки человека. О влиянии на клетки человека таких наносоединений, как фуллерены, известно очень мало. Для использования новых производных фуллерена в медицине необходимо охарактеризовать общий ответ клеток на присутствие различных концентраций фуллерена в среде. В данной работе исследовано влияние одного из представителей этого класса - производного фуллерена С60 F-828, содержащего 3-фенилпропионильные заместители и атом хлора на эмбриональные фибробласты легкого человека (ФЛЭЧ). Было обнаружено, что исследуемое соединение увеличивает пролиферативную активность ФЛЭЧ в диапазоне концентраций 4 нМ - 0.1 мкМ. Все исследованные концентрации вызывают повреждения ДНК и усиливают процессы репарации. В концентрациях, превышающих 20 мкМ, исследованное соединение вызывает некротическую клеточную смерть, блокируя апоптоз и, таким образом, является цитотоксичным.</p>
   </abstract>
   <trans-abstract xml:lang="en">
    <p>It is a matter of common knowledge that C60 fullerenes and their derivatives have antioxidant properties due to their chemical structure. Studies show that these substances also possess antiviral and anticancer activity, moreover, they are under studies as potential nanocarriers for drug delivery across biological barriers. But the effect of such derivatives on human cells is still controversially discussed and needs further investigation. Here we assessed the time-dependent effect of a water soluble fullerene derivative that contains five residues of 3-phenylpropionic acid and a chlorine substituent attached to the carbon cage (F-828) on human embryonic lung fibroblasts (HELFs). Investigated substance increases proliferation of HELFs in concentration range 4 nM - 0.1 µM. All concentrations of F-828 cause DNA damage and give rise to reparation process. In concentrations exceeding 20 µM F-828 causes necrotic cell death, blocks apoptosis, and is therefore cytotoxic.</p>
   </trans-abstract>
   <kwd-group xml:lang="ru">
    <kwd>наномедицина</kwd>
    <kwd>фуллерены</kwd>
    <kwd>некроз</kwd>
    <kwd>ФЛЭЧ</kwd>
   </kwd-group>
   <kwd-group xml:lang="en">
    <kwd>fullerene derivatives</kwd>
    <kwd>necrosis</kwd>
    <kwd>HELFs</kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <p></p>
 </body>
 <back>
  <ref-list>
   <ref id="B1">
    <label>1.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Yang X., Ebrahimi A., Li J., Cui Q. Fullerene-biomolecule conjugates and their biomedicinal applications, Int J Nanomedicine, 2014, vol. 9, pp. 77-92.</mixed-citation>
     <mixed-citation xml:lang="en">Yang X., Ebrahimi A., Li J., Cui Q. Fullerene-biomolecule conjugates and their biomedicinal applications, Int J Nanomedicine, 2014, vol. 9, pp. 77-92.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B2">
    <label>2.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Grebowski J., Kazmierska P., Krokosz A. Fullerenols as a new therapeutic approach in nanomedicine, Biomed Res Int [Online], 2013, р. 751913.</mixed-citation>
     <mixed-citation xml:lang="en">Grebowski J., Kazmierska P., Krokosz A. Fullerenols as a new therapeutic approach in nanomedicine, Biomed Res Int [Online], 2013, r. 751913.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B3">
    <label>3.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Nakamura S., Mashino T. Water-soluble fullerene derivatives for drug discovery, J Nippon Med Sch., 2012, vol. 79, pp. 248-254.</mixed-citation>
     <mixed-citation xml:lang="en">Nakamura S., Mashino T. Water-soluble fullerene derivatives for drug discovery, J Nippon Med Sch., 2012, vol. 79, pp. 248-254.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B4">
    <label>4.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Bullard-Dillard R., Creek K.E., Scrivens W.A., Tour J.M., Tissue sites of uptake of 14C labelled C60. Bioorg. Chem., 1996, vol. 24, no. 4, pp. 376-385.</mixed-citation>
     <mixed-citation xml:lang="en">Bullard-Dillard R., Creek K.E., Scrivens W.A., Tour J.M., Tissue sites of uptake of 14C labelled C60. Bioorg. Chem., 1996, vol. 24, no. 4, pp. 376-385.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B5">
    <label>5.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Rouse J.G., Yang J., Barron A.R., Monteiro-Riviere N.A. Fullerene-based amino acid nanoparticle interactions with human epidermal keratinocytes. Toxicol. In Vitro, 2006, vol. 20, no. 8, pp. 1313-1320.</mixed-citation>
     <mixed-citation xml:lang="en">Rouse J.G., Yang J., Barron A.R., Monteiro-Riviere N.A. Fullerene-based amino acid nanoparticle interactions with human epidermal keratinocytes. Toxicol. In Vitro, 2006, vol. 20, no. 8, pp. 1313-1320.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B6">
    <label>6.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Sayes C.M., Marchione, A.A., Reed K.L., Warheit D.B. Comparative pulmonary toxicity assessments of C60 water suspensions in rats: few differences in fullerene toxicity in vivo in contrast to in vitro profiles. Nano Lett., 2007, vol. 7, no. 8, pp. 2399-2406.</mixed-citation>
     <mixed-citation xml:lang="en">Sayes C.M., Marchione, A.A., Reed K.L., Warheit D.B. Comparative pulmonary toxicity assessments of C60 water suspensions in rats: few differences in fullerene toxicity in vivo in contrast to in vitro profiles. Nano Lett., 2007, vol. 7, no. 8, pp. 2399-2406.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B7">
    <label>7.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Vistica D.T., Skehan P., Scudiero D., Monks A., Pittman A., Boyd M.R. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res., 1991, vol. 51, pp. 2515-2520.</mixed-citation>
     <mixed-citation xml:lang="en">Vistica D.T., Skehan P., Scudiero D., Monks A., Pittman A., Boyd M.R. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res., 1991, vol. 51, pp. 2515-2520.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B8">
    <label>8.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Holder A.L., Goth-Goldstein R., Lucas D., Koshland C.P. Particle-induced artifacts in the MTT and LDH viability assays. Chem Res Toxicol, 2012, vol. 17, pp. 1885-1892.</mixed-citation>
     <mixed-citation xml:lang="en">Holder A.L., Goth-Goldstein R., Lucas D., Koshland C.P. Particle-induced artifacts in the MTT and LDH viability assays. Chem Res Toxicol, 2012, vol. 17, pp. 1885-1892.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B9">
    <label>9.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Monteiro-Riviere N.A., Inman A.O., Zhang L.W. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol, 2009, vol. 234, pp. 222-235.</mixed-citation>
     <mixed-citation xml:lang="en">Monteiro-Riviere N.A., Inman A.O., Zhang L.W. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol, 2009, vol. 234, pp. 222-235.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B10">
    <label>10.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Moore J.O., Palep S.R., Saladi R.N., Gao D., Wang Y., Phelps R.G., Lebwohl M.G., Wei H. Effects of ultraviolet B exposure on the expression of proliferating cell nuclear antigen in murine skin. Photochem Photobiol, 2004, vol. 80, pp. 587-595.</mixed-citation>
     <mixed-citation xml:lang="en">Moore J.O., Palep S.R., Saladi R.N., Gao D., Wang Y., Phelps R.G., Lebwohl M.G., Wei H. Effects of ultraviolet B exposure on the expression of proliferating cell nuclear antigen in murine skin. Photochem Photobiol, 2004, vol. 80, pp. 587-595.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B11">
    <label>11.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Shivji K.K., Kenny M.K., Wood R.D. Proliferating cell nuclear antigen is required for DNA excision repair. Cell, 1992, vol. 69, pp. 367-374.</mixed-citation>
     <mixed-citation xml:lang="en">Shivji K.K., Kenny M.K., Wood R.D. Proliferating cell nuclear antigen is required for DNA excision repair. Cell, 1992, vol. 69, pp. 367-374.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B12">
    <label>12.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Löbrich M., Shibata A., Beucher A., Fisher A., Ensminger M., Goodarzi A.A., Barton O., Jeggo P.A. GammaH2AX foci analysis for monitoring DNA doublestrand break repair: strengths, limitations and optimization. Cell Cycle, 2010, vol. 9, pp. 662-669.</mixed-citation>
     <mixed-citation xml:lang="en">Löbrich M., Shibata A., Beucher A., Fisher A., Ensminger M., Goodarzi A.A., Barton O., Jeggo P.A. GammaH2AX foci analysis for monitoring DNA doublestrand break repair: strengths, limitations and optimization. Cell Cycle, 2010, vol. 9, pp. 662-669.</mixed-citation>
    </citation-alternatives>
   </ref>
  </ref-list>
 </back>
</article>
